{
    "id": 11974,
    "fullName": "TFE3 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "TFE3 positive indicates the presence of the TFE3 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 7030,
        "geneSymbol": "TFE3",
        "terms": [
            "TFE3",
            "bHLHe33",
            "RCCP2",
            "RCCX1",
            "TFEA"
        ]
    },
    "variant": "positive",
    "createDate": "09/16/2015",
    "updateDate": "10/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3176,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II clinical study, cediranib resulted in an objective response rate of 35% and a disease control rate of 84% at 24 weeks in 43 patients evaluated for response with TFE3 positivity confirmed in 26 patients with alveolar soft part sarcoma (PMID: 23630200).",
            "molecularProfile": {
                "id": 12070,
                "profileName": "TFE3 positive"
            },
            "therapy": {
                "id": 1001,
                "therapyName": "Cediranib",
                "synonyms": null
            },
            "indication": {
                "id": 4239,
                "name": "alveolar soft part sarcoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 3627,
                    "pubMedId": 23630200,
                    "title": "Cediranib for metastatic alveolar soft part sarcoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23630200"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 12070,
            "profileName": "TFE3 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}